Reliance Seeks Drug Regulator’s Permission To Repurpose Tapeworm Drug For Covid-19 Treatment
RIL’s team has also designed a process to produce sanitizers aligned with WHO specifications at 20% of market cost, RIL said in its annual report.
Share
